Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

JAZ “Targeting” Compounds Induce G1 Cell Cycle Arrest Followed by Cell Death in Human Leukemia Cells

Mingli Yang, PhD, George Q. Yang, Jinghua Jia, Ph.D., David Ostrov, Ph.D., W. Stratford May, M.D., Ph.D.

Blood (2008) 112 (11): 2658.

https://doi.org/10.1182/blood.V112.11.2658.2658

Published: 2008

Journal Articles

Activation of JAZ by Small Molecules in Human Leukemia Cells.

Mingli Yang, PhD, Jinghua Jia, Ph.D., David Ostrov, Ph.D., Jingxin Qiu, M.D., Ph.D., W. Stratford May, M.D., Ph.D.

Blood (2007) 110 (11): 2652.

https://doi.org/10.1182/blood.V110.11.2652.2652

Published: 2007

Journal Articles

RAX Activates Tumor Suppressor p53.

Yu Pan, PhD, Richard L. Bennett, Ph.D., W. Stratford May, M.D.,Ph.D.

Blood (2006) 108 (11): 1449.

https://doi.org/10.1182/blood.V108.11.1449.1449

Published: 2006

Journal Articles

Protein Phosphatase 2A Inactivates Bcl2’s Antiapoptotic Function by Dephosphorylation and Up-Regulation of Bcl2-p53 Binding.

Xingming Deng, MD, Fengqin Gao, Tammy Flagg, W. Stratford May, M.D., Ph.D.

Blood (2006) 108 (11): 1436.

https://doi.org/10.1182/blood.V108.11.1436.1436

Published: 2006

Journal Articles

JAZ Is Required for Interlukin-3 Withdrawal-Induced Apoptosis by Directly Activating p53.

Mingli Yang, PhD, Jingxin Qiu, M.D., Ph.D., Ying Li, M.D., Ph.D., Jinghua Jia, Ph.D., W. Stratford May, M.D., Ph.D.

Blood (2006) 108 (11): 1445.

https://doi.org/10.1182/blood.V108.11.1445.1445

Published: 2006

Journal Articles

Inhibition of Bcl-2 Signaling at Nanomolar Concentrations by Small Molecule BH3 Inhibitor, ABT-737 as a Novel Therapeutic Strategy in Acute Myeloid Leukemia (AML).

Rooha Contractor, Marina Konopleva, M.D., Ph.D., Xingming Deng, M.D., Ph.D., David Harris, Peter Ruvolo, Ph.D., Zeev Estrov, M.D., W. Stratford May, M.D., Ph.D., Saul H. Rosenberg, Ph.D., Michael Andreeff, M.D., Ph.D.

Blood (2004) 104 (11): 760.

https://doi.org/10.1182/blood.V104.11.760.760

Published: 2004

NARROW

JAZ “Targeting” Compounds Induce G1 Cell Cycle Arrest Followed by Cell Death in Human Leukemia Cells

Activation of JAZ by Small Molecules in Human Leukemia Cells.

RAX Activates Tumor Suppressor p53.

Protein Phosphatase 2A Inactivates Bcl2’s Antiapoptotic Function by Dephosphorylation and Up-Regulation of Bcl2-p53 Binding.

JAZ Is Required for Interlukin-3 Withdrawal-Induced Apoptosis by Directly Activating p53.

Inhibition of Bcl-2 Signaling at Nanomolar Concentrations by Small Molecule BH3 Inhibitor, ABT-737 as a Novel Therapeutic Strategy in Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

JAZ “Targeting” Compounds Induce G1 Cell Cycle Arrest Followed by Cell Death in Human Leukemia Cells

Activation of JAZ by Small Molecules in Human Leukemia Cells.

RAX Activates Tumor Suppressor p53.

Protein Phosphatase 2A Inactivates Bcl2’s Antiapoptotic Function by Dephosphorylation and Up-Regulation of Bcl2-p53 Binding.

JAZ Is Required for Interlukin-3 Withdrawal-Induced Apoptosis by Directly Activating p53.

Inhibition of Bcl-2 Signaling at Nanomolar Concentrations by Small Molecule BH3 Inhibitor, ABT-737 as a Novel Therapeutic Strategy in Acute Myeloid Leukemia (AML).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only